Related Experiment Video
Updated: Jan 31, 2026

Integrated Compensatory Responses in a Human Model of Hemorrhage
Published on: November 20, 2016
Single nanomolar doxorubicin exposure triggers compensatory mitochondrial responses in H9c2 cardiomyoblasts
Luciana L Ferreira1, Teresa Cunha-Oliveira1, Caroline D Veloso1
1CNC - Center for Neuroscience and Cell Biology, University of Coimbra, UC Biotech Building, Biocant Park, 3060-197, Cantanhede, Portugal.
Abstract:
Dose-dependent and cumulative cardiotoxicity associated with doxorubicin (DOX) is the main limitation of anticancer therapy. Pediatric cancer survivors are particularly vulnerable, and no effective prevention measures are available. The aim of the present study was to investigate the persistent effects of nanomolar DOX concentrations and determine whether a pretreatment would induce mitochondrial adaptations in H9c2 cardiomyoblasts. H9c2 cells were incubated with DOX (10 and 25 nM) for 24 h, followed by 9 days of recovery in drug-free medium. We found that the sub-therapeutic DOX treatment induced persistent hypertrophy and dose-dependent cell cycle arrest in G2/M. Glycolytic activity, indirectly based on extracellular acidification rate, and basal respiration were significantly decreased in DOX-treated cells compared to controls, although both groups showed similar maximal respiration. Additionally, nanomolar DOX pretreatment resulted in upregulation of mitochondrial DNA transcripts accompanied by a decrease in DNA methyltransferase 1 (DNMT1) and global methylation levels. Finally, the pretreatment with DOX ameliorated H9c2 cells resistance against a subsequent exposure to DOX. These results suggest that nanomolar DOX pretreatment induced a beneficial and possibly epigenetic-based mitochondrial adaptation, raising the possibility that an early sub-therapeutic DOX treatment can be used as a preconditioning and protective approach during anticancer therapies.
Insights
Low-dose doxorubicin (DOX) pretreatment may protect heart cells from damage. This study found that nanomolar DOX induced mitochondrial adaptations and increased resistance to subsequent DOX exposure in H9c2 cardiomyoblasts.
Area of Science:
- Cardiology
- Molecular Biology
- Pharmacology
Background:
- Doxorubicin (DOX) causes dose-dependent cardiotoxicity, limiting its use in cancer therapy.
- Pediatric cancer survivors face persistent risks, with no current prevention strategies.
- Understanding sub-therapeutic DOX effects on heart cells is crucial for developing protective measures.
Purpose of the Study:
- Investigate persistent effects of nanomolar DOX on H9c2 cardiomyoblasts.
- Determine if DOX pretreatment induces protective mitochondrial adaptations.
- Explore potential epigenetic mechanisms underlying DOX-induced protection.
Main Methods:
- H9c2 cardiomyoblasts were incubated with 10 and 25 nM DOX for 24 hours, followed by 9 days of recovery.
- Assessed cell hypertrophy, cell cycle progression, glycolytic activity, and mitochondrial respiration.
- Analyzed mitochondrial DNA transcripts, DNA methyltransferase 1 (DNMT1) levels, and global methylation.
Main Results:
- Sub-therapeutic DOX induced persistent hypertrophy and G2/M cell cycle arrest.
- Decreased glycolytic activity and basal respiration were observed, with similar maximal respiration.
- DOX pretreatment upregulated mitochondrial DNA transcripts and decreased DNMT1 and global methylation.
- Pretreated cells showed enhanced resistance to subsequent DOX exposure.
Conclusions:
- Nanomolar DOX pretreatment induces beneficial mitochondrial adaptations in H9c2 cardiomyoblasts.
- These adaptations may be epigenetically mediated, involving changes in DNA methylation.
- Early sub-therapeutic DOX exposure could serve as a preconditioning strategy to protect against DOX cardiotoxicity.
Related Concept Videos
Export of Mitochondrial and Chloroplast Genes
Animal Mitochondrial Genetics
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Photoreceptors and Plant Responses to Light
The Inner Mitochondrial Membrane
Responses to Gravity and Touch

